Get the Facts and Tools You Need to Help Support Your Patients Receiving DARZALEX®

Share

DARZALEX® (daratumumab)
Redefining approaches in early lines of multiple myeloma

How DARZALEX® works

DARZALEX® is not chemotherapy. It is an immunotherapy that works with the immune system. DARZALEX® targets a specific protein on multiple myeloma cells and may also affect normal cells with this protein. DARZALEX® can cause serious side effects, including infusion reactions and decreases in blood cell counts. See Important Safety Information below.1

DARZALEX® Mechanism of Action

Rd=lenalidomide (R) + dexamethasone (d).